Literature DB >> 21474992

Epigenetic DNA methylation in the promoters of the Igf1 receptor and insulin receptor genes in db/db mice.

Andrej Nikoshkov1, Vivekananda Sunkari, Octavian Savu, Elisabete Forsberg, Sergiu-Bogdan Catrina, Kerstin Brismar.   

Abstract

We have investigated promoter methylation of the Insr, Igf1 and Igf1r genes in skeletal and cardiac muscles of normal and diabetic db/db mice. No differences in Insr promoter methylation were found in the heart and skeletal muscles and no methylation was detected in the Igf1 promoter in skeletal muscle. In skeletal muscle, db/db males exhibited a 7.4-fold increase in Igf1r promoter methylation, which was accompanied by a 1.8-fold decrease in Igf1r mRNA levels, compared with controls. More than 50% of the detected methylation events were concentrated within an 18 bp sequence that includes one of the Sp1 binding sites. We conclude that the methylation level and pattern of the Igf1r promoter in skeletal muscle is related to gender and the diabetic state.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474992     DOI: 10.4161/epi.6.4.14791

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  16 in total

Review 1.  What obesity research tells us about epigenetic mechanisms.

Authors:  Neil A Youngson; Margaret J Morris
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-05       Impact factor: 6.237

Review 2.  Epigenetic modifications in the pathogenesis of diabetic nephropathy.

Authors:  Marpadga A Reddy; Jung Tak Park; Rama Natarajan
Journal:  Semin Nephrol       Date:  2013-07       Impact factor: 5.299

3.  MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes.

Authors:  Vishalakshi Chavali; Suresh C Tyagi; Paras K Mishra
Journal:  Biochem Biophys Res Commun       Date:  2012-07-27       Impact factor: 3.575

4.  Anti-diabetic effect of a novel oligosaccharide isolated from Rosa canina via modulation of DNA methylation in Streptozotocin-diabetic rats.

Authors:  Gholamreza Bahrami; Soraya Sajadimajd; Bahareh Mohammadi; Razieh Hatami; Shahram Miraghaee; Samira Keshavarzi; Mozafar Khazaei; Seyed Hamid Madani
Journal:  Daru       Date:  2020-08-03       Impact factor: 3.117

5.  DNA demethylation enhances myoblasts hypertrophy during the late phase of myogenesis activating the IGF-I pathway.

Authors:  Pamela Senesi; Livio Luzi; Anna Montesano; Ileana Terruzzi
Journal:  Endocrine       Date:  2013-12-24       Impact factor: 3.633

6.  Reduced insulin-like growth factor I receptor and altered insulin receptor isoform mRNAs in normal mucosa predict colorectal adenoma risk.

Authors:  M Agostina Santoro; Sarah F Andres; Joseph A Galanko; Robert S Sandler; Temitope O Keku; P Kay Lund
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-13       Impact factor: 4.254

Review 7.  Role of maternal vitamins in programming health and chronic disease.

Authors:  Emanuela Pannia; Clara E Cho; Ruslan Kubant; Diana Sánchez-Hernández; Pedro S P Huot; G Harvey Anderson
Journal:  Nutr Rev       Date:  2016-02-16       Impact factor: 7.110

Review 8.  Epigenetic modifications and diabetic nephropathy.

Authors:  Marpadga A Reddy; Jung Tak Park; Rama Natarajan
Journal:  Kidney Res Clin Pract       Date:  2012-07-21

9.  IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma.

Authors:  Ling Gao; Xiaolong Wang; Xiaofei Wang; Linmei Zhang; Cui Qiang; Su'e Chang; Wenhao Ren; Shaoming Li; Yang Yang; Dongdong Tong; Cheng Chen; Zongfang Li; Tusheng Song; Keqian Zhi; Chen Huang
Journal:  Oncotarget       Date:  2014-05-15

Review 10.  Insulin-like growth factors and their potential role in cardiac epigenetics.

Authors:  Cristiana Iosef Husted; Maria Valencik
Journal:  J Cell Mol Med       Date:  2016-04-07       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.